UWM Researchers Look to Create Pill for Asthma

Scientists at the University of Wisconsin-Milwaukee (UWM) were notified that the National Institutes of Health will fund a 4-year program to develop a new drug therapy for asthma.

Asthma is a growing health care problem, with an estimated global prevalence of 245 million individuals – nearly 25 million afflicted in the U.S. alone (about 8.2% of the population). It is the most common chronic disease of children with disparate impact in US minority populations. While several drugs are used extensively to combat asthma symptoms, they are not always effective, disease may become resistant, and side effects can occur.

TMJ4 news story.